TP Therapeutics
Clinical-stage structure-based drug design company for the discovery and development of precision medicines for cancer and other diseases.
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor investor investor | €0.0 | round | |
| investor investor investor investor investor investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
* | $4.1b Valuation: $4.1b | Acquisition | |
| Total Funding | 000k | ||
SR One(exited)
Cormorant Asset Management(exited)
Lilly Asia Ventures(exited)
OrbiMed(exited)
SV Tech Ventures(exited)
CRCM Ventures(exited)
Foresite Capital(exited)
Kenson Ventures(exited)
Nextech Invest(exited)
venBio Partners(exited)
Harbinger Ventures(exited)
HBM Partners(exited)
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.